US FDA rejects China-tested cancer drugs, foils Hutchmed’s first shot at US market by Editor | May 4, 2022 | Government, Regulatory & Policy News, Hospitals, LATEST NEWS, WORLD NEWS | 0 USA – The US Food and Drug Administration has rejected two proposed new cancer drugs developed in... Read More